These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11760488)

  • 1. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
    Bourgault C; Elstein E; Baltzan MA; Le Lorier J; Suissa S
    Pharmacoepidemiol Drug Saf; 2001; 10(4):287-94. PubMed ID: 11760488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
    J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
    Schelleman H; Klungel OH; Witteman JC; Breteler MM; Yazdanpanah M; Danser AH; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2007 Apr; 15(4):478-84. PubMed ID: 17299437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study.
    Lindberg G; Lindblad U; Löw-Larsen B; Merlo J; Melander A; Råstam L
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):493-7. PubMed ID: 12426934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
    Blackburn DF; Lamb DA; Eurich DT; Johnson JA; Wilson TW; Dobson RT; Blackburn JL
    J Hypertens; 2007 Jul; 25(7):1499-505. PubMed ID: 17563574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction.
    Sauer WH; Baer JT; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Nov; 94(9):1171-3. PubMed ID: 15518614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
    Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
    Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
    Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.
    L'Allier PL; Ducharme A; Keller PF; Yu H; Guertin MC; Tardif JC
    J Am Coll Cardiol; 2004 Jul; 44(1):159-64. PubMed ID: 15234426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive medications and risk of community-acquired pneumonia.
    Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
    J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
    Leader S; Mallick R; Roht L
    J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
    Baer JT; Sauer WH; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.